Comparison of the Four Anhydrous Polymorphs of Carbamazepine and the Crystal Structure of Form I

Journal of Pharmaceutical Sciences

Volumn 92, Issue 11, 2003, Pages 2260-2271

  Grzesiak, Adam L ^a   Lang, Meidong ^a   Kim, Kibum ^a   Matzger, Adam J ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Calorimetry (DSC); Crystal structure; Hydrogen bond; Polymorphism; X ray diffractometry

Indexed keywords

CARBAMAZEPINE;

ARTICLE; COMPARATIVE STUDY; CRYSTAL STRUCTURE; DIFFERENTIAL SCANNING CALORIMETRY; DRUG CONFORMATION; DRUG STABILITY; HIGH TEMPERATURE; HYDROGEN BOND; INFRARED SPECTROSCOPY; MICROSCOPY; X RAY POWDER DIFFRACTION;

EID: 0242322069     PISSN: 00223549     EISSN: None     Source Type: Journal    
DOI: 10.1002/jps.10455     Document Type: Article

References (41)

1. Bernstein J, Davey RJ, Henck JO. 1999. Concomitant polymorphs. Angew Chem Int Ed Engl 38:3441-3461.
2. Kariuki BM, Bauer CL, Harris KDM, Teat SJ. 2000. Polymorphism in p-hydroxybenzoic acid: The effect of intermolecular hydrogen bonding in controlling proton order versus disorder in the carboxylic acid dimer motif. Angew Chem Int Ed Engl 39:4485-4488.
3. Gavezzotti A, Filippini G. 1995. Polymorphic forms of organic crystals at room conditions: Thermodynamic and structural implications. J Am Chem Soc 117:12299-12305.
4. Dunitz JD, Bernstein J. 1995. Disappearing polymorphs. Acc Chem Res 28:193-200.
5. Steiner T. 1997. Unrolling the hydrogen bond properties of C-H⋯O interactions. Chem Commun 727-734.
6. Brittain HG. 1999. Polymorphism in pharmaceutical solids. New York: Marcel Dekker.
7. Brock CP. 1996. Investigations of the systematics of crystal packing using the Cambridge Structural Database. J Res Natl Inst Stand Technol 101:321-325.
8. Henck JO, Griesser UJ, Burger A. 1997. Polymorphism of drug substances: An economic challenge. Pharm Ind 59:165-169.
9. McCrone WC. 1957. Fusion methods in chemical microscopy. New York: Interscience Publishers.
10. Desiraju GR. 1991. The C-H⋯O hydrogen-bond in crystals: What is it? Acc Chem Res 24:290-296.
11. Desiraju GR. 1997. Designer crystals: Intermolecular interactions, network structures, and supramolecular synthons. Chem Commun 1475-1482.
12. Yu L, Reutzel-Edens SM, Mitchell CA. 2000. Crystallization and polymorphism of conformationally flexible molecules: Problems, patterns, and strategies. Org Process Res Dev 4:396-402.
13. Kuhnert-Brandstätter M, Kofler A, Vlachopoulos A. 1968. Beitrag zur mikroskopischen Charakterisierung und Identifizierung von Arzneimitteln unter Einbeziehung der UV-Spektrophotometrie. Sci Pharm 36:164-179.
14. Pohlmann H, Gulde C, Jahn R, Pfeifer S. 1975. Polymorphism, particle-size and blood level values of carbamazepine. Pharmazie 30:709-711.
15. Reboul JP, Cristau B, Soyfer JC, Astier JP. 1981. 5H-5-Dibenz[b,f]azepinecarboxamide-5 (carbamazepine). Acta Crystallogr Sect B 37:1844-1848.
16. Himes VL, Mighell AD, De Camp WH. 1981. Structure of carbamazepine: 5H-Dibenz[b,f]azepine-5-carboxamide. Acta Crystallogr Sect B 37:2242-2245.
17. Kaneniwa N, Yamaguchi T, Watari N, Otsuka M. 1984. Hygroscopicity of carbamazepine crystalline powders. Yakugaku Zasshi 104:184-190.
18. Umeda T, Ohnishi N, Yokohama T, Kuroda K, Kuroda T, Tatsumi E, Matsuda Y. 1984. Kinetics of the thermal transition of carbamazepine polymorphic forms in the solid state. Yakugaku Zasshi 104:786-792.
19. Kala H, Haack U, Pollandt P, Brezesinski G. 1986. Zur Polymorphie des Carbamazepins. Acta Pharm Technol 32:72-77.
20. Lefebvre C, Guyot-Hermann AM, Draguet-Brughmans M, Bouche R, Guyot JC. 1986. Polymorphic transitions of carbamazepine during grinding and compression. Drug Dev Ind Pharm 12:1913-1927.
21. Krahn FU, Mielck JB. 1987. Relations between several polymorphic forms and the dihydrate of carbamazepine. Pharm Acta Helv 62:247-254.
22. Lowes MMJ, Caira MR, Lötter AP, van der Watt JG. 1987. Physicochemical properties and X-Ray structural studies of the trigonal polymorph of carbamazepine. J Pharm Sci 76:744-752.
23. Lisgarten JN, Palmer RA, Saldanha JW. 1989. Crystal and molecular structure of 5-carbamyl-5H-dibenzo[b,f]azepine. J Crystallogr Spectrosc Res 19:641-649.
24. Behme RJ, Brooke D. 1991. Heat of fusion measurement of a low melting polymorph of carbamazepine that undergoes multiple-phase changes during differential scanning calorimetry analysis. J Pharm Sci 80:986-990.
25. Dugué J, Céolin R, Rouland JC, Lepage F. 1991. Polymorphism of carbamazepine: Solid-state studies on carbamazepine dihydrate. Pharm Acta Helv 66:307-310.
26. Borka L, Lonmo A, Winsnes R. 1992. Semiquantitative IR spectroscopy of the crystal polymorphs of carbamazepine: A special case in the Ph. Eur. and USP. Pharm Acta Helv 67:231-233.
27. McMahon LE, Timmins P, Williams AC, York P. 1996. Characterization of dihydrates prepared from carbamazepine polymorphs. J Pharm Sci 85:1064-1069.
28. Céolin R, Toscani S, Gardette MF, Agafonov VN, Dzyabchenko AV, Bachet B. 1997. X-ray characterization of the triclinic polymorph of carbamazepine. J Pharm Sci 86:1062-1065.
29. Roberts RJ, Payne RS, Rowe RC. 2000. Mechanical property predictions for polymorphs of sulphathiazole and carbamazepine. Eur J Pharm Sci 9:277-283.
30. Kobayashi Y, Ito S, Itai S, Yamamoto K. 2000. Physicochemical properties and bioavailability of carbamazepine polymorphs and dihydrate. Int J Pharm 193:137-146.
31. Rustichelli C, Gamberini G, Ferioli V, Gamberini MC, Ficarra R, Tommasini S. 2000. Solid-state study of polymorphic drugs: Carbamazepine. J Pharm Biomed Anal 23:41-54.
32. Lang M, Kampf JW, Matzger AJ. 2002. Form IV of carbamazepine. J Pharm Sci 91:1186-1190.
33. 3O. Memoirs of Osaka Kyoiku University, Series III 36:93-97.
34. Bar I, Bernstein J. 1985. Conformational polymorphism. IV. The crystal and molecular structures of form II, form III, and form V of 4-amino-N-2-pyridinylbenzenesulfonamide (sulfapyridine). J Pharm Sci 74:255-263.
35. Yu L, Stephenson GA, Mitchell CA, Bunnell CA, Snorek SV, Bowyer JJ, Borchardt TB, Stowell JG, Byrn SR. 2000. Thermochemistry and conformational polymorphism of a hexamorphic crystal system. J Am Chem Soc 122:585-591.
36. Hughes DS, Hursthouse MB, Threlfall T, Tavener S. 1999. A new polymorph of sulfathiazole. Acta Crystallogr Sect C 55:1831-1833.
37. Lang M, Grzesiak AL, Matzger AJ. 2002. The use of polymer heteronuclei for crystalline polymorph selection. J Am Chem Soc 124:14834-14835.
38. Bernstein J, Davis RE, Shimoni L, Chang NL. 1995. Patterns in hydrogen bonding: Functionality and graph set analysis in crystals. Angew Chem Int Ed Engl 34:1555-1573.
39. Etter MC. 1990. Encoding and decoding hydrogen-bond patterns of organic compounds. Acc Chem Res 23:120-126.
40. Burger A, Ramberger R. 1979. On the polymorphism of pharmaceuticals and other organic molecular crystals. I. Theory of thermodynamic rules. Mikrochim Acta II:259-271.
41. Lommerse JPM, Motherwell WDS, Ammon HL, Dunitz JD, Gavezzotti A, Hofmann DWM, Leusen FJJ, Mooij WTM, Price SL, Schweizer B, Schmidt MU, van Eijck BP, Verwer P, Williams DE. 2000. A test of crystal structure prediction of small organic molecules. Acta Crystallogr Sect B 56:697-714.